Total Quality Management
How can we maintain the quality
“Quality should be built into the product”
- Starting to end process
- It start from the purchase of materials, equipment
& hiring right people
- Beyond manufacturing activities
- safe distribution of the product till the ultimate
customers
- getting feedback to improve quality of product
- for maintaining quality it requires control on facilities,
equipment, materials, processes and testing
QUALITY
 Grade of excellence
 Meeting the requirements of the customer
 A state of being free from defects, deficiencies and significant variations
 The totality of features and characteristics of a product or service that bears its ability
to satisfy stated needs
 A pharmaceutical product which meet the following 5 characteristics-
i) Identity (name and contents of product)
ii) Strength (complete strength statement )
iii) Safety (safety of ultimate users or patient)
iv) Purity (free from any cross contamination)
v) Efficacy (getting desired effect)
Higher quality enables company to
 Increase customer satisfaction
 Make products salable
 Meet competition
 Increase market share
 Provide sales income
Objectives of Quality Management
 Provide high quality drug product to patients
 Reduce number of recalls, returned & defective product
entering the market place
 Harmonize the c GMP
 To handle many types of changes to facilitate,
equipment and processes
 To help in getting quality by design
 To achieve success in business improving risk
management and thus increases profitability
Quality Management System
 Quality
 Quality by design and Product development
 Risk management and risk assessment
-RM(establishing specification & process parameters)
-RA(need for investigation & taking necessary corrective action)
 Corrective and preventive action (CAPA)
- correcting discrepancies and attempting to prevent recurrence
 Change control
-focusing on managing change & preventing unintended
consequences
 The quality unit
» Quality Assurance (testing)
» Quality Control (review-approval-maintance)
Six system inspection models
 The FDA’s Drug Manufacturing Inspection
Compliance programme is system based and it carries
evaluation of 6 quality systems
– Production
– Facilities and equipment
– Materials
– Packaging and labeling
– Laboratory control
– Overall quality system
• System based(it assess whether each of the system
is in a state of control)
QMS
EVALUATION
ACTIVITIES
RESOURCES
MANUFACTURING
OPERATION
MANAGEMENT
RESPOSIBILITIES
COMPONENTS OF Q.M.S.
 W.H.O. guidelines of GMP define quality management
as-
“The aspect of management function that determine and
implements the Quality Policy”
1) An appropriate infrastructure of ‘quality system’
considering organizational structure, procedure and
recourses
2) Systematic action necessary to check product.
Code of Federal Regulations (CFR)
The Code of Federal Regulations (CFR) is the
codification of the general and permanent rules
and regulations (sometimes called administrative
law) published in the Federal Register by the
executive departments and agencies of
the federal government of the United States.
QUALITYASSURANCE
 Quality assurance is a wide ranging concept covering
all matters that individually or collectively influence
the quality of a product.
 It is the totality of the arrangements made with the
object of ensuring that pharmaceutical products are of
the quality required for their intended use.
 QA is the heart and soul of quality control
 QA = QC + GMP /Other Quality Systems Quality
Raw material Top Management
Customer Customer Complaints
 According to QA, products are designed and
developed in a way that takes account of the
requirements of GMP and other associated codes such
as those of good laboratory practice (GLP) and good
clinical practice (GCP).
 Product and control operations are clearly specified in
a written form and GMP requirements are adopted.
 Arrangements are made for the manufacture, supply
and use of the correct starting and packaging
materials.
 All necessary controls on starting materials,
intermediate products, and bulk products and other
in-process controls, calibrations, and validations are
carried out
 The finished products is correctly processed and checked
according to the defined procedures.
 Products are not sold or supplied before the authorized persons
have certified that each production batch has been produced
and controlled in accordance with the requirements of the
marketing authorization and any other regulations relevant to
the production, control and release of products.
 Satisfactory arrangements exist to ensure, as far as possible,
that the pharmaceutical products are stored by the
manufacturer, distributed and subsequently handled so that
quality is maintained throughout their shelf- life.
 There is a procedure for self-inspection and/or quality audit
that regularly appraises the effectiveness and applicability of
the quality assurance system.
 Regular evaluations of the quality of pharmaceutical
products should be conducted with the objective of
verifying the consistency of the process and ensuring
its continuous improvement.
 Evaluation and Analysis of the Deviations, Out of
Specification results and Change Controls during the
Manufacturing.
 Complaint handling.
 Documentation of the process from staring material
to the end user and its storage.
 Stability studies
QC
GMP
QA
QC
Quality relationships
Quality Management
Quality Assurance
GMP
Quality Control
Quality control (QC)
 Quality control (QC) includes the activities from the
suppliers, through production, and to the customers.
 Incoming materials are examined to make sure they
meet the appropriate specifications.
 The quality of partially completed products are
analyzed to determine if production processes are
functioning properly.
 Finished goods and services are studied to determine
if they meet customer expectations.
QC Throughout Production Systems
Raw Materials,
Parts, and
Supplies
Production
Processes
Products and
Services
Inputs Conversion Outputs
Control Charts
and
Acceptance Tests
Control Charts
and
Acceptance Tests
Control Charts
Quality of
Inputs
Quality of
Outputs
Quality of
Partially Completed
Products
Definition by WHO:
 Q.C. is the part of GMP concerned with sampling,
specification, testing, with the organization,
documentation and release procedures which ensures
that necessary and relevant test are actually carried out
and that materials are neither release for use.
Definition by MCC South Africa:
 Q.C. is the part of GMP concerned which is concerned
with the organization, documentation and release
procedures which ensure that necessary and relevant test
are actually carried out that materials are not release for
use, not product release for sale or supply, until their
quality has been judged to be satisfactory.
Components of Quality Control:
 The independence of Q.C. from production.
 Adequate facilities, trained personnel and approved
procedures must be available for sampling, inspection
and testing of starting material.
 Q.C. Lab should have
- testing lab should have chemical, glassware, reagent
- instruments like HPLC,GC,FTIR
- provision for stability sample
- documentation room
- various books like pharmacopeias, microbiology,
analytical chemistry
 Q.C. lab should have trained personnel's
 Q.C. lab should have SOP related sampling and
testing, instrumental analysis
- do as you have written (SOP)
- write you have done (records)
 The method must be validated
 Sufficient sample of starting materials and products
must be kept as retained to permit further
examination of the product if necessary.
Goal of QC
 To detect significant errors rapidly
 Report out good results in a timely manner
 Be cost effective and simple to use
 If there is an error, identify the source of the error
GOOD MANUFACTURING PRACTICE
 Def by WHO
“GMP is the part of quality assurance that products
are consistently produced and controlled to the
quality standards appropriate to their intended use and
as required by the marketing authorization”
 Def by MCC South Africa
“GMP is the part of quality assurance that products
are consistently produced and controlled to the
quality standards appropriate to their intended use and
the legal requirement. It is concerned with both
production and quality control matters”
Various Aspects of GMP
 Personnel
 Buildings and facilities
 Raw materials
 Equipment
 Storage
 Waste disposal.
Comments:
 GMP is a part of QA
 GMP’s main function is to produce quality product
consistently
 GMP must meet legal requirement of the country
 GMP must deal with both production and QC related
issues
 Mainly GMP diminish the risk of mixups and
contamination
Components of GMP
 All manufacturing processes should be clearly defined
 Critical steps of manufacturing processes and any significant
changes made to the process validated
 All necessary facilities are provided including
- qualified trained personnel's
- adequate premises and space
- suitable equipment and services
- correct materials, containers and label
- approved procedures and instruction
- suitable storage and transport
 Operators are trained to carry out procedures correctly
 Records are made during manufacturer to show that all the steps
 The proper storage and distribution of the product minimizes any
risk of their quality.
Sampling
 One can not always non destructively analyze the
materials and hence small sample/population of the
material is collected as representative samples and tested
for its quality.
 If not……….
 Hence the entire sampling activities get lots of attention
of all the regulatory bodies.
 Various points covered include-
– Sampling area
– Sampling of sterile products
– Sampling procedures
– Reference sample
– Sampling of IPQC materials
– Sampling of finished and packed material
Sampling area
 There should be separate area for-
–API, Excipients, sterile materials
–Liquids, hazardous, poisonous and explosive
materials
–In process, bulk, finished and bulk
–Primary, secondary and tertiary packaging
materials
Sampling of sterile product
 Shall be conducted in aseptic conditions
 Sterile equipment, sterile product and aseptic
sampling shall be used.
Sampling procedure
 CFR 211.210
 To avoid contamination or others adverse effects on
quality
Following procedures are followed for sampling
 Containers should be cleaned
 Containers shall be opened, sampled and resealed
 Sterile equipment, aseptic sampling techniques
 Containers from which samples have been taken shall
be marked
Reference sample
 It is a representative sample of a substance used in
manufacturer of a pharmaceutical product as also the
sample of the finished pharmaceutical product.
Sampling of IPQC materials
 USFDA gives specific guideline on IPQC sampling and
testing in CFR 211.11.
 Purpose: to assure batch uniformity and integrity of the
drug product.
 For tab: weight variation, dissolution time, disintegration
time
 For liquid: clarity, pH
 Semi solid: viscosity
Specification of finished bulk and packed
finished product
Testing
• Testing of material is one of the main activity in QC
department which involve testing of following
materials namely,
– Active and inactive pharmaceutical ingredients
– 1° ,2 ° and other packaging materials
– In process materials
– Finished bulk product
– Finished packed product
Regulatory guidelines are available for following
areas:
 Analytical method validation
 Laboratory reagent used in testing
 Calculation verification
 Use of laboratory animal
 Special testing requirement
 Test record
 Release of finished product
 Legal requirement
Analytical method validation
 These procedure includes stability studies must be
validated to demonstrate their reliability
 Revalidation of analytical method becomes necessary
in-
– Change in synthesis of a drug substance
– Change in the composition of a finished products
– Change in the analytical procedure
Typical validation characters which should be
considered are- accuracy, precision, specificity,
LOD, LOQ, Linearity and range
Laboratory reagent used in testing
 Every lab should have sufficient quantity of all
reagents required for testing.
 Results of testing depends upon quality of reagents
 SOP should be available for making and
standardizing reagents.
 Records of such preparation and standardization be
kept in a register.
 Prepared reagents must be properly labeled
– Name and strength
– Shelf life and date of preparation
– Storage condition
Calculation verification
 All analytical calculations carried out by analyst must
be checked and verified by a competent person before
the report is accepted
Use of laboratory animal
 Animal used in testing shall be maintained and
controlled
 They must be identified and records must be
maintained
 They must be appropriately quarantined before use
Special testing requirement
• SOP should be available for following test
– Pyrogen testing
– Sterility testing
– Bacterial endotoxin test
– Test for foreign particles
Self inspection and quality audits
1) Self inspection
 evaluate the manufacturer compliance with GMP
 detect any short coming in the implementation
 can be performed routinely
 may be inhouse or carried out by local regulatory authorities
For self inspection SOP should cover the
-items for self inspection
-self inspection team
-frequency of self inspection
-self inspection report
-follow up action
Quality Audit
 Examination and assessment of all parts of a quality
system with a specific purpose of improving it
 Conducted by outside or independent specialist or a
team designated by the management for this purpose.
2) Total Quality Managment

2) Total Quality Managment

  • 1.
  • 2.
    How can wemaintain the quality “Quality should be built into the product” - Starting to end process - It start from the purchase of materials, equipment & hiring right people - Beyond manufacturing activities - safe distribution of the product till the ultimate customers - getting feedback to improve quality of product - for maintaining quality it requires control on facilities, equipment, materials, processes and testing
  • 3.
    QUALITY  Grade ofexcellence  Meeting the requirements of the customer  A state of being free from defects, deficiencies and significant variations  The totality of features and characteristics of a product or service that bears its ability to satisfy stated needs  A pharmaceutical product which meet the following 5 characteristics- i) Identity (name and contents of product) ii) Strength (complete strength statement ) iii) Safety (safety of ultimate users or patient) iv) Purity (free from any cross contamination) v) Efficacy (getting desired effect)
  • 4.
    Higher quality enablescompany to  Increase customer satisfaction  Make products salable  Meet competition  Increase market share  Provide sales income
  • 5.
    Objectives of QualityManagement  Provide high quality drug product to patients  Reduce number of recalls, returned & defective product entering the market place  Harmonize the c GMP  To handle many types of changes to facilitate, equipment and processes  To help in getting quality by design  To achieve success in business improving risk management and thus increases profitability
  • 6.
    Quality Management System Quality  Quality by design and Product development  Risk management and risk assessment -RM(establishing specification & process parameters) -RA(need for investigation & taking necessary corrective action)  Corrective and preventive action (CAPA) - correcting discrepancies and attempting to prevent recurrence  Change control -focusing on managing change & preventing unintended consequences  The quality unit » Quality Assurance (testing) » Quality Control (review-approval-maintance)
  • 7.
    Six system inspectionmodels  The FDA’s Drug Manufacturing Inspection Compliance programme is system based and it carries evaluation of 6 quality systems – Production – Facilities and equipment – Materials – Packaging and labeling – Laboratory control – Overall quality system • System based(it assess whether each of the system is in a state of control)
  • 8.
  • 9.
    COMPONENTS OF Q.M.S. W.H.O. guidelines of GMP define quality management as- “The aspect of management function that determine and implements the Quality Policy” 1) An appropriate infrastructure of ‘quality system’ considering organizational structure, procedure and recourses 2) Systematic action necessary to check product.
  • 10.
    Code of FederalRegulations (CFR) The Code of Federal Regulations (CFR) is the codification of the general and permanent rules and regulations (sometimes called administrative law) published in the Federal Register by the executive departments and agencies of the federal government of the United States.
  • 14.
    QUALITYASSURANCE  Quality assuranceis a wide ranging concept covering all matters that individually or collectively influence the quality of a product.  It is the totality of the arrangements made with the object of ensuring that pharmaceutical products are of the quality required for their intended use.  QA is the heart and soul of quality control  QA = QC + GMP /Other Quality Systems Quality
  • 15.
    Raw material TopManagement Customer Customer Complaints
  • 16.
     According toQA, products are designed and developed in a way that takes account of the requirements of GMP and other associated codes such as those of good laboratory practice (GLP) and good clinical practice (GCP).  Product and control operations are clearly specified in a written form and GMP requirements are adopted.  Arrangements are made for the manufacture, supply and use of the correct starting and packaging materials.  All necessary controls on starting materials, intermediate products, and bulk products and other in-process controls, calibrations, and validations are carried out
  • 17.
     The finishedproducts is correctly processed and checked according to the defined procedures.  Products are not sold or supplied before the authorized persons have certified that each production batch has been produced and controlled in accordance with the requirements of the marketing authorization and any other regulations relevant to the production, control and release of products.  Satisfactory arrangements exist to ensure, as far as possible, that the pharmaceutical products are stored by the manufacturer, distributed and subsequently handled so that quality is maintained throughout their shelf- life.  There is a procedure for self-inspection and/or quality audit that regularly appraises the effectiveness and applicability of the quality assurance system.
  • 18.
     Regular evaluationsof the quality of pharmaceutical products should be conducted with the objective of verifying the consistency of the process and ensuring its continuous improvement.  Evaluation and Analysis of the Deviations, Out of Specification results and Change Controls during the Manufacturing.  Complaint handling.  Documentation of the process from staring material to the end user and its storage.  Stability studies
  • 19.
  • 20.
  • 21.
    Quality control (QC) Quality control (QC) includes the activities from the suppliers, through production, and to the customers.  Incoming materials are examined to make sure they meet the appropriate specifications.  The quality of partially completed products are analyzed to determine if production processes are functioning properly.  Finished goods and services are studied to determine if they meet customer expectations.
  • 22.
    QC Throughout ProductionSystems Raw Materials, Parts, and Supplies Production Processes Products and Services Inputs Conversion Outputs Control Charts and Acceptance Tests Control Charts and Acceptance Tests Control Charts Quality of Inputs Quality of Outputs Quality of Partially Completed Products
  • 23.
    Definition by WHO: Q.C. is the part of GMP concerned with sampling, specification, testing, with the organization, documentation and release procedures which ensures that necessary and relevant test are actually carried out and that materials are neither release for use. Definition by MCC South Africa:  Q.C. is the part of GMP concerned which is concerned with the organization, documentation and release procedures which ensure that necessary and relevant test are actually carried out that materials are not release for use, not product release for sale or supply, until their quality has been judged to be satisfactory.
  • 24.
    Components of QualityControl:  The independence of Q.C. from production.  Adequate facilities, trained personnel and approved procedures must be available for sampling, inspection and testing of starting material.  Q.C. Lab should have - testing lab should have chemical, glassware, reagent - instruments like HPLC,GC,FTIR - provision for stability sample - documentation room - various books like pharmacopeias, microbiology, analytical chemistry
  • 25.
     Q.C. labshould have trained personnel's  Q.C. lab should have SOP related sampling and testing, instrumental analysis - do as you have written (SOP) - write you have done (records)  The method must be validated  Sufficient sample of starting materials and products must be kept as retained to permit further examination of the product if necessary.
  • 26.
    Goal of QC To detect significant errors rapidly  Report out good results in a timely manner  Be cost effective and simple to use  If there is an error, identify the source of the error
  • 27.
    GOOD MANUFACTURING PRACTICE Def by WHO “GMP is the part of quality assurance that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization”  Def by MCC South Africa “GMP is the part of quality assurance that products are consistently produced and controlled to the quality standards appropriate to their intended use and the legal requirement. It is concerned with both production and quality control matters”
  • 28.
    Various Aspects ofGMP  Personnel  Buildings and facilities  Raw materials  Equipment  Storage  Waste disposal.
  • 29.
    Comments:  GMP isa part of QA  GMP’s main function is to produce quality product consistently  GMP must meet legal requirement of the country  GMP must deal with both production and QC related issues  Mainly GMP diminish the risk of mixups and contamination
  • 30.
    Components of GMP All manufacturing processes should be clearly defined  Critical steps of manufacturing processes and any significant changes made to the process validated  All necessary facilities are provided including - qualified trained personnel's - adequate premises and space - suitable equipment and services - correct materials, containers and label - approved procedures and instruction - suitable storage and transport  Operators are trained to carry out procedures correctly  Records are made during manufacturer to show that all the steps  The proper storage and distribution of the product minimizes any risk of their quality.
  • 31.
    Sampling  One cannot always non destructively analyze the materials and hence small sample/population of the material is collected as representative samples and tested for its quality.  If not……….  Hence the entire sampling activities get lots of attention of all the regulatory bodies.  Various points covered include- – Sampling area – Sampling of sterile products – Sampling procedures – Reference sample – Sampling of IPQC materials – Sampling of finished and packed material
  • 32.
    Sampling area  Thereshould be separate area for- –API, Excipients, sterile materials –Liquids, hazardous, poisonous and explosive materials –In process, bulk, finished and bulk –Primary, secondary and tertiary packaging materials
  • 33.
    Sampling of sterileproduct  Shall be conducted in aseptic conditions  Sterile equipment, sterile product and aseptic sampling shall be used. Sampling procedure  CFR 211.210  To avoid contamination or others adverse effects on quality Following procedures are followed for sampling  Containers should be cleaned  Containers shall be opened, sampled and resealed  Sterile equipment, aseptic sampling techniques  Containers from which samples have been taken shall be marked
  • 35.
    Reference sample  Itis a representative sample of a substance used in manufacturer of a pharmaceutical product as also the sample of the finished pharmaceutical product. Sampling of IPQC materials  USFDA gives specific guideline on IPQC sampling and testing in CFR 211.11.  Purpose: to assure batch uniformity and integrity of the drug product.  For tab: weight variation, dissolution time, disintegration time  For liquid: clarity, pH  Semi solid: viscosity
  • 36.
    Specification of finishedbulk and packed finished product
  • 37.
    Testing • Testing ofmaterial is one of the main activity in QC department which involve testing of following materials namely, – Active and inactive pharmaceutical ingredients – 1° ,2 ° and other packaging materials – In process materials – Finished bulk product – Finished packed product
  • 38.
    Regulatory guidelines areavailable for following areas:  Analytical method validation  Laboratory reagent used in testing  Calculation verification  Use of laboratory animal  Special testing requirement  Test record  Release of finished product  Legal requirement
  • 39.
    Analytical method validation These procedure includes stability studies must be validated to demonstrate their reliability  Revalidation of analytical method becomes necessary in- – Change in synthesis of a drug substance – Change in the composition of a finished products – Change in the analytical procedure Typical validation characters which should be considered are- accuracy, precision, specificity, LOD, LOQ, Linearity and range
  • 40.
    Laboratory reagent usedin testing  Every lab should have sufficient quantity of all reagents required for testing.  Results of testing depends upon quality of reagents  SOP should be available for making and standardizing reagents.  Records of such preparation and standardization be kept in a register.  Prepared reagents must be properly labeled – Name and strength – Shelf life and date of preparation – Storage condition
  • 41.
    Calculation verification  Allanalytical calculations carried out by analyst must be checked and verified by a competent person before the report is accepted Use of laboratory animal  Animal used in testing shall be maintained and controlled  They must be identified and records must be maintained  They must be appropriately quarantined before use
  • 42.
    Special testing requirement •SOP should be available for following test – Pyrogen testing – Sterility testing – Bacterial endotoxin test – Test for foreign particles
  • 43.
    Self inspection andquality audits 1) Self inspection  evaluate the manufacturer compliance with GMP  detect any short coming in the implementation  can be performed routinely  may be inhouse or carried out by local regulatory authorities For self inspection SOP should cover the -items for self inspection -self inspection team -frequency of self inspection -self inspection report -follow up action
  • 44.
    Quality Audit  Examinationand assessment of all parts of a quality system with a specific purpose of improving it  Conducted by outside or independent specialist or a team designated by the management for this purpose.